UNITY BIOTECHNOLOGY INC (UBX)
US91381U2006 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.80M | 12.70M | 32.90M | 17.80M | 37.50M | |||
| Marketable Securities | 23.40M | 82.10M | 55.20M | 79.90M | 90.00M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 3.40M | 1.70M | 2.50M | 3.20M | 2.00M | |||
| Total Current Assets | 46.60M | 96.50M | 90.50M | 100.90M | 129.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 18.06M | 26.90M | 31.20M | 36.10M | 16.60M | |||
| Investments And Advances | N/A | 0.00 | 2.00M | 17.90M | 3.00M | |||
| Other Non-Current Assets | 1.02M | 900.00K | 1.00M | 1.40M | 2.10M | |||
| Total Non-Current Assets | 19.09M | 27.90M | 34.20M | 55.40M | 21.70M | |||
| TOTAL ASSETS | 65.69M | 124.40M | 124.70M | 156.30M | 151.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 9.50M | 3.10M | 0.00 | 0.00 | |||
| Accrued Expenses | 6.46M | 8.40M | 10.40M | 11.90M | 9.00M | |||
| Accounts Payable | 1.38M | 1.80M | 2.00M | 2.60M | 5.20M | |||
| Other Current Liabilities | N/A | 0.00 | 1.20M | 0.00 | 3.00M | |||
| Total Current Liabilities | 7.84M | 19.60M | 16.60M | 14.50M | 17.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 10.90M | 18.40M | 24.50M | 0.00 | |||
| Other Non-Current Liabilities | 29.45M | 27.00M | 30.10M | 34.50M | 13.30M | |||
| Total Non-Current Liabilities | 29.45M | 37.90M | 48.50M | 58.90M | 13.30M | |||
| TOTAL LIABILITIES | 37.29M | 57.50M | 65.10M | 73.40M | 30.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -484.35M | -460.00M | -400.00M | -339.30M | -245.50M | |||
| Additional Paid In Capital | 512.77M | 527.00M | 459.60M | 422.40M | 366.70M | |||
| Common Shares | 2.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | -200.00K | -600.00K | |||
| Shares Outstanding | 16.78M | 14.20M | 6.30M | 5.30M | 4.70M | |||
| Tangible Book Value per Share | 1.69 | 4.70 | 9.46 | 15.64 | 25.68 | |||
| Total Shareholders' Equity | 28.40M | 66.80M | 59.60M | 82.90M | 120.70M | |||
| TOTAL LIABILITIES AND EQUITY | 65.69M | 124.40M | 124.70M | 156.30M | 151.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.16 | 0.31 | 0.30 | N/A | |||
| Current Ratio | 5.94 | 4.92 | 5.45 | 6.96 | 7.53 | |||
| Return On Assets (ROA) | -60.68% | -48.18% | -48.70% | -60.04% | -54.35% | |||
| Return On Equity (ROE) | -140.36% | -89.72% | -101.90% | -113.20% | -68.09% | |||
All data in USD